DOI QR코드

DOI QR Code

Oral Contraceptives, Abortion and Breast Cancer Risk: a Case Control Study in Saudi Arabia

  • Karim, Syed Mustafa (Department of Oncology, King Faisal Specialist Hospital and Research Center) ;
  • Baeshen, Wijdan (Research Center, King Faisal Specialist Hospital and Research Center) ;
  • Neamatullah, Syed Nehal (Department of Family Medicine, King Faisal Specialist Hospital and Research Center) ;
  • Bin, Bakr (Department of Oncology, King Faisal Specialist Hospital and Research Center)
  • Published : 2015.05.18

Abstract

Background: Several studies have examined the relationship between oral contraceptive pill (OCP) use, abortions and breast cancer, with mixed results. Hormonal changes associated with OCP use and abortion may increase risk of breast cancer over time, but there is a lack of studies studying this association in Saudi Arabian women. Materials and Methods: We thererfore conducted a case control study in 192 women (92 as cases and 100 as controls), aged 30 to 65, and collected information on variables including examples related to study objectives and those which may confound findings. The Chi square test was used to detect associations between various factors and risk of breast cancer. Results: We found no evidence of interaction between history of abortion or frequency of abortion and breast cancer risk (Chi square=0.422, p =0.420 and 1, p =0.169) respectively. Oral contraceptives did not confer risk for breast cancer overall (OR=0.276, 95%CI 0.092-0.829, p=0.524), while long term use of OCP was associated with increased risk of breast cancer (OR=0.297, 95%CI 0.158-0.557, p=0.001), with higher association for those who used 10 years or more of OCPs (OR=0.282, 95%CI 0.095-0.835, p=0.02). Age at first use of OCPs had no effect on breast cancer risk (p=0.452) or age at diagnosis (p=0.074). Conclusions: Prolonged use of OC (more than 10 years) may be associated with increased risk of breast cancer in Saudi women. Larger population based studies are needed to confirm this finding in this population.

Keywords

Oral contraceptives;breast cancer risk;abortion;Saudi Arabia

References

  1. ABCSG (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian breast cancer study group. Br J Cancer, 83, 1301-8. https://doi.org/10.1054/bjoc.2000.1407
  2. Amin TT, Al Mulhim AR, Al Meqihwi A (2009). Breast cancer knowledge, risk factors and screening among adult Saudi women in a primary health care setting. Asian Pac J Cancer Prev, 10, 133-8.
  3. Anders CK, Johnson R, Litton J, et al (2009). Breast cancer before age 40 years. Semin Oncol, 36, 237-49. https://doi.org/10.1053/j.seminoncol.2009.03.001
  4. Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, et al (2013). Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health, 25, 368-87. https://doi.org/10.1177/1010539513488795
  5. Assi HA, Khoury KE, Dbouk H, et al (2013). Epidemiology and prognosis of breast cancer in young women. J Thorac Dis, 5, 2072-1439.
  6. Beral V, Bull D, Doll R, et al (2004). Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet, 363, 1007-16. https://doi.org/10.1016/S0140-6736(04)15835-2
  7. Boyle P, Howell A (2010). The globalisation of breast cancer. Breast Cancer Res, 12, 7.
  8. Cancer CGoHFiB (1996). Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713-27. https://doi.org/10.1016/S0140-6736(96)90806-5
  9. Carmichael AR, Bates T (2004). Obesity and breast cancer: a review of the literature. Breast, 13, 85-92. https://doi.org/10.1016/j.breast.2003.03.001
  10. Danaei G, Vander Hoorn S, Lopez AD, et al (2005). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 366, 1784-93. https://doi.org/10.1016/S0140-6736(05)67725-2
  11. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  12. Fredholm H, Eaker S, Frisell J, et al (2009). Breast cancer in young women: poor survival despite intensive treatment. PloS one, 4, 7695. https://doi.org/10.1371/journal.pone.0007695
  13. Hankinson SE, Colditz GA, Manson JE, et al (1997). A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Control, 8, 65-72. https://doi.org/10.1023/A:1018435205695
  14. Hannaford PC, Selvaraj S, Elliott AM, et al (2007). Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ, 335, 11.
  15. Howe HL, Senie RT, Bzduch H, et al (1989). Early abortion and breast cancer risk among women under age 40. Int J Epidemiol, 18, 300-4. https://doi.org/10.1093/ije/18.2.300
  16. Marchbanks PA, McDonald JA, Wilson HG, et al (2002). Oral contraceptives and the risk of breast cancer. N Engl J Med, 346, 2025-32. https://doi.org/10.1056/NEJMoa013202
  17. Melbye M, Wohlfahrt J, Olsen JH, et al (1997). Induced abortion and the risk of breast cancer. N Engl J Med, 336, 81-5. https://doi.org/10.1056/NEJM199701093360201
  18. Moorman PG, Havrilesky LJ, Gierisch JM, et al (2013). Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and metaanalysis. J Clin Oncol, 31, 4188-98. https://doi.org/10.1200/JCO.2013.48.9021
  19. Organization WH. Breast cancer: prevention and control [Online]. Available: http://www.who.int/cancer/detection/breastcancer/en/index2.html.
  20. Reeves GK, Kan SW, Key T, et al (2006). Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer, 119, 1741-5. https://doi.org/10.1002/ijc.22001
  21. Uyeturk U, Tatli AM, Gucuk S, et al (2013). Risk factors for stage IV breast cancer at the time of presentation in Turkey. Asian Pac J Cancer Prev, 14, 7445-9. https://doi.org/10.7314/APJCP.2013.14.12.7445
  22. Vaisy A, Lotfinejad S, Zhian F (2014). Risk of cancer with combined oral contraceptive use among Iranian women. Asian Pac J Cancer Prev, 15, 5517-22. https://doi.org/10.7314/APJCP.2014.15.14.5517
  23. Vessey M, Yeates D (2013). Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study. Contraception, 88, 678-83. https://doi.org/10.1016/j.contraception.2013.08.008
  24. Xing P, Li J, Jin F (2010). A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol, 27, 926-31. https://doi.org/10.1007/s12032-009-9308-7
  25. Zhang Q, Liu L-y, Wang F, et al (2012). The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health, 12, 368. https://doi.org/10.1186/1471-2458-12-368

Cited by

  1. Reproductive risk factors associated with breast cancer in women in Bangui: a case–control study vol.17, pp.1, 2017, https://doi.org/10.1186/s12905-017-0368-0
  2. Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014 vol.2017, pp.2090-3189, 2017, https://doi.org/10.1155/2017/2481021
  3. Induced abortion and breast cancer vol.97, pp.3, 2018, https://doi.org/10.1097/MD.0000000000009613
  4. Induced Abortion, Birth Control Methods, and Breast Cancer Risk: A Case-Control Study in China pp.1349-9092, 2018, https://doi.org/10.2188/jea.JE20170318